Francis O. Walker, M.D.
Professor, Neurology
Contact Information
Academic: 336-716-7548 | Department: 336-716-7548
Recent Publications
Cartwright MS, Hobson-Webb LD, Boon AJ, Alter KE, Hunt CH, Flores VH, Werner RA, Shook SJ, Thomas TD, Primack SJ, Walker FO.
Evidence-based guideline: neuromuscular ultrasound for the diagnosis of carpal tunnel syndrome. Muscle Nerve. 2012;46(2):287-293.
Walker FO, Cartwright MS, eds.
In: Neuromuscular ultrasound. Philadelphia: Elsevier/Saunders;2011: .
Walker FO.
Interventional ultrasound In: Walker FO, Cartwright MS, eds. Neuromuscular ultrasound. Philadelphia: Elsevier/Saunders;2011: 150-165.
Cartwright MS, White DL, Demar S, Wiesler ER, Sarlikiotis T, Chloros GD, Yoon JS, Won SJ, Molnar JA, Defranzo AJ, Walker FO.
Median nerve changes following steroid injection for carpal tunnel syndrome. Muscle Nerve. 2011;44(1):25-29.
Pankratz N, Dumitriu A, Hetrick KN, Sun M, Latourelle JC, Wilk JB, Halter C, Doheny KF, Gusella JF, Nichols WC, Myers RH, Foroud T, DeStefano AL, Walker F, Hunt V, O'Neill C, et al.
Copy number variation in familial Parkinson disease. PLoS ONE. 2011;6(8):e20988.
Latourelle JC, Hendricks AE, Pankratz N, Wilk JB, Halter C, Nichols WC, Gusella JF, Destefano AL, Myers RH, Foroud T, Walker F, Hunt V, O'Neill C, et al.
Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease. Mov Disord. 2011;26(11):2039-2044.
Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Walker F, et al.
A randomized, placebo-controlled trial of latrepirdine in Huntington disease. Arch Neurol. 2010;67(2):154-160.
Beglinger LJ, O'Rourke JJ, Wang C, Langbehn DR, Duff K, Paulsen JS, Hedges P, McCusker E, Hunt V, Walker F, et al.
Earliest functional declines in Huntington disease. Psychiatry Res. 2010;178(2):414-418.
Hyson HC, Kieburtz K, Shoulson I, McDermott M, Ravina B, de Blieck EA, Cudkowicz ME, Ferrante RJ, Walker F, Hunt V, et al.
Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects. Mov Disord. 2010;25(12):1924-1928.
Quaid KA, Swenson MM, Sims SL, Harrison JM, Moskowitz C, Stepanov N, Suter GW, Caress J, Walker F, Hunt V, et al.
What were you thinking?: individuals at risk for Huntington Disease talk about having children. J Genet Couns. 2010;19(6):606-617.
Schwarz H, Hickey C, Zimmerman C, Mazzoni P, Moskowitz C, Rosas D, McCall M, Sanchez-Ramos J, Perlmutter J, Walker F, et al.
A futility study of minocycline in Huntington's disease. Mov Disord. 2010;25(13):2219-2224.
Simon DK, Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Nichols WC, Foroud T, Walker F, Hunt V, O'Neill C, et al.
Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease. BMC Med Genet. 2010;11():53.
Latourelle JC, Pankratz N, Dumitriu A, Wilk JB, Goldwurm S, Pezzoli G, Mariani CB, DeStefano AL, Halter C, Gusella JF, Nichols WC, Myers RH, Foroud T, Walker F, Hunt V, O'Neill C, et al.
Genomewide association study for onset age in Parkinson disease. BMC Med Genet. 2009;10():98.
Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, Pugh EW, Doheny KF, Gusella JF, Nichols WC, Foroud T, Myers RH, Walker F, Hunt V, O'Neill C, et al.
Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet. 2009;124(6):593-605.
Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Walker F, Hunt V, et al.
A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Clin Neuropharmacol. 2008;31(3):127-133.
Beglinger LJ, Langbehn DR, Duff K, Stierman L, Black DW, Nehl C, Anderson K, Penziner E, Hunt V, Walker F, et al.
Probability of obsessive and compulsive symptoms in Huntington's disease. Biol Psychiatry. 2007;61(3):415-418.
Nichols WC, Marek DK, Pauciulo MW, Pankratz N, Halter CA, Rudolph A, Shults CW, Wojcieszek J, Walker F, Hunt V, et al.
R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation. Mov Disord. 2007;22(2):254-257.
Duff K, Beglinger LJ, Schultz SK, Moser DJ, McCaffrey RJ, Haase RF, Westervelt HJK, Langbehn DR, Walker F, Hunt V, et al.
Practice effects in the prediction of long-term cognitive outcome in three patient samples: a novel prognostic index. Arch Clin Neuropsychol. 2007;22(1):15-24.
Langbehn DR, Paulsen JS, Hedges P, McCusker E, Pearce S, Trent R, Abwender D, Como P, Hunt V, Walker F, et al.
Predictors of diagnosis in Huntington disease. Neurology. 2007;68(20):1710-1717.
Smith R, Ferrario C, Walker F. Number of antihypertensive agents required to achieve goal blood pressure with an Olmesartan Medoxomil vs Atenolol based regimen [abstract]. J Hypertens. 2007;25(Suppl 2):S240-S241.
Cartwright MS, Chloros GD, Walker FO, Wiesler ER, Campbell WW. Diagnostic ultrasound for nerve transection [abstract]. Ann Neurol. 2006;60(5):636.
Shoulson I, Kieburtz K, Oakes D, Kayson E, Zhao H, Shinaman A, Romer M, Caress J, Walker F, Hunt V, et al.
At risk for Huntington disease: the PHAROS (Prospective Huntington At Risk Observational Study) Cohort enrolled. Arch Neurol. 2006;63(7):991-996.
Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Wojcieszek J, Rudolph A, Shults CW, Walker F, Hunt V, et al.
Mutations in DJ-I are rare in familial Parkinson disease. Neurosci Lett. 2006;408(3):209-213.
Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Walker F, Hunt V, et al.
Mutations in LRRK2 other than G2019S are rare in a North American-based sample of familial Parkinson's disease. Mov Disord. 2006;21(12):2257-2260.
Walker FO.
Autonomic testing In: Kimura J, ed. Peripheral nerve diseases. Edinburgh: Elsevier;2006: 487-509.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.